Vasospastic Angina Clinical Trial
Official title:
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Pletaal(Cilostazol) in Subjects With Vasospastic Angina
This study will be conducted in accordance with the local regulation of New Drug
Application. Overall duration of this trial will be 3 years after approval of KFDA.
Each subject will participate around 7 weeks, which include the 2 weeks Amlodipine run-in
period, 4 weeks double blind period and 1 week safety follow up period
A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel group, Therapeutic
confirmatory Study.
The subject who has at least one episode of chest pain weekly and at least two episodes of
chest pain during last week despite Amlodipine 5mg qd taking during 2 weeks will have
treatment of Pletaal(Cilostazol) or Placebo for 4 weeks. Pletaal(Cilostazol) is taken 100mg
oral tablets bid during 2 weeks after dosing of Pletaal(Cilostazol) 50mg oral tablets bid
during 2 weeks. Placebo of Pletaal(Cilostazol) is used as the control medication.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04827498 -
Myocardial Ischemia Without Obstructive Coronary Stenoses
|
||
Recruiting |
NCT05294887 -
Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease
|
Phase 4 | |
Recruiting |
NCT06401291 -
Transcutaneous Electrical Nerve Stimulation in Patients With Angina and Non-Obstructive Coronary Arteries
|
N/A | |
Recruiting |
NCT05313919 -
Coronary Microcirculatory Disease and Inflammation in Patients With Chronic Coronary Syndrome and no Significant Coronary Artery Stenosis
|
||
Not yet recruiting |
NCT06424834 -
Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06415227 -
The Impact of Vericiguat on Microvascular Function in Patients With Documented Vasospastic Angina Pectoris
|
Phase 2 | |
Recruiting |
NCT05282511 -
A Multi-Omics Study of Vasospastic Angina
|
||
Recruiting |
NCT04674449 -
iCorMicA - Stratified Medicine in Angina
|
N/A | |
Completed |
NCT02094469 -
Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina
|
Phase 3 | |
Recruiting |
NCT02180971 -
Multidetector Coronary CT In Vasospastic Angina
|
N/A | |
Completed |
NCT00601302 -
Bioequivalency Study of Amlodipine Tablets Under Fed Conditions
|
N/A | |
Completed |
NCT00602017 -
Bioequivalency Study of Amlodipine Tablets Under Fasting Conditions
|
N/A |